New Haven, CT, United States of America

Elias Quijano

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • New Haven, CT (US) (2021)
  • Durham, CT (US) (2023 - 2024)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Elias Quijano

Introduction

Elias Quijano is a notable inventor based in New Haven, CT, with a significant contribution to the field of gene editing. He holds a total of six patents that focus on enhancing the efficiency of genetic modifications. His work is pivotal in advancing the methodologies used in genetic engineering.

Latest Patents

Quijano's latest patents include "Compositions and methods for enhancing donor oligonucleotide-based gene editing" and "Compositions and methods for delivery of nucleic acids to cells." The first patent describes a composition that includes a cell-penetrating antibody and a donor oligonucleotide designed to correct mutations in a cell's genome. This innovative approach allows for genomic modifications at a higher frequency both ex vivo and in vivo. The second patent outlines methods for delivering nucleic acid cargo into cells, utilizing a monoclonal antibody or a cell-penetrating fragment to facilitate the process.

Career Highlights

Throughout his career, Quijano has worked with prestigious institutions such as Yale University and Carnegie Mellon University. His research has significantly impacted the field of genetic engineering, particularly in the development of more effective gene editing techniques.

Collaborations

Quijano has collaborated with esteemed colleagues, including Peter M. Glazer and W. Mark Saltzman, who have contributed to his research endeavors and innovations.

Conclusion

Elias Quijano's contributions to gene editing through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence advancements in genetic engineering and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…